Search hospitals > Missouri > Kansas City
University of Kansas Cancer Center
Claim this profileKansas City, Missouri 64131
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
Conducts research for Pancreatic Cancer
435 reported clinical trials
47 medical researchers
Summary
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Prostate Cancer, Pancreatic Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 569 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Jun ZhangHouston Methodist Hospital5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
28 reported clinical trials
43 drugs studied
Chao H. HuangUniversity of Kansas Health System Saint Francis Campus6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
35 drugs studied
Anwaar SaeedUniversity of Kansas Cancer Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Liver Cancer
20 reported clinical trials
37 drugs studied
Gary C. DoolittleSalina Regional Health Center2 years of reported clinical research
Studies Melanoma
Studies Lung Cancer
20 reported clinical trials
36 drugs studied
Clinical Trials running at University of Kansas Cancer Center
Lung Cancer
Breast Cancer
Skin Cancer
Breast cancer
Prostate Cancer
Bladder Cancer
Cancer
Pancreatic Cancer
Lymphoma
Non-Hodgkin's Lymphoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Kansas Cancer Center?
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Prostate Cancer, Pancreatic Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 569 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.
Where is University of Kansas Cancer Center located?
The University of Kansas Cancer Center offers comprehensive medical oncology services at its facility located at 12200 West 110th Street, Overland Park, KS 66210. For inquiries or to schedule an appointment, please call 913-588-1227.
Who should I call to ask about financial aid or insurance network?
The University of Kansas Cancer Center offers comprehensive support services for cancer patients, including emotional, nutritional, financial, and genetic counseling, personal appearance services, and rehabilitation. Patients eligible for financial assistance, with a gross family income between 0% to 300% of the federal poverty guidelines, can apply through the University of Kansas Health System. For more details or to make an appointment, contact 913-588-1227 or toll-free at 844-323-1227.
What insurance does University of Kansas Cancer Center accept?
The University of Kansas Cancer Center accepts a wide range of insurance plans, including those through the University of Kansas Medical Center for its employees, covering medical, dental, vision, disability, long-term care, life insurance, and wellness programs. Additionally, it accepts various plans on the open marketplace, including Aetna CareLink, BCBS Kansas, Sunflower or Home State/Ambetter, Oscar, and Blue Cross Blue Shield of Kansas City/Blue Select. It's important to verify with your physician that they participate with your insurance plan or network before seeking services.
What awards or recognition has University of Kansas Cancer Center received?
The University of Kansas Cancer Center, located in Kansas City, Missouri, is recognized as a Comprehensive cancer center by the National Cancer Institute (NCI), a prestigious status shared with only 53 centers nationwide. This distinction is accompanied by a five-year, $13.8 million grant aimed at bolstering the center's research efforts. In partnership with the Stowers Institute for Medical Research and Children's Mercy Kansas City, the center enhances its research capabilities and extends its services to high-risk and underserved communities.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.